Next Article in Journal
Oxytocin: Old Hormone, New Drug
Next Article in Special Issue
Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets
Previous Article in Journal / Special Issue
Coenzyme Q10 and Neurological Diseases
Open AccessReview

Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies

Departments of Neurology and Molecular and Integrative Physiology, University of Kansas School of Medicine, Kansas City, MO, Kansas 66160, USA
Pharmaceuticals 2009, 2(3), 150-167; https://doi.org/10.3390/ph2030150
Received: 19 November 2009 / Revised: 27 November 2009 / Accepted: 2 December 2009 / Published: 3 December 2009
(This article belongs to the Special Issue Mitochondrial Drugs for Neurodegenerative Diseases)
Neurodegenerative diseases are a common late-life scourge for which diseasemodifying treatments are sorely needed. Mitochondrial perturbation is commonly observed in these diseases, so pursuing treatment development strategies that target mitochondria or processes affected by mitochondria seems reasonable. This review discusses the rationale underlying past and current efforts to treat neurodegenerative diseases using mitochondrial medicine, and tries to predict how future efforts might proceed. View Full-Text
Keywords: mitochondria; mitochondrial biogenesis; mitochondriopathies; neurodegenerative diseases; oxidative stress mitochondria; mitochondrial biogenesis; mitochondriopathies; neurodegenerative diseases; oxidative stress
Show Figures

Figure 1

MDPI and ACS Style

Swerdlow, R.H. Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies. Pharmaceuticals 2009, 2, 150-167.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop